NSF at 2019 IPEC Europe Annual Excipients Forum in Malta

Published: 15-Jan-2019
Pharmaceutical


Join NSF at this dynamic conference in Malta on 31 January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe. At 8.45am, NSF International's Dr Pete Gough, Executive Director, Pharma Biotech, will deliver a session on the potential impacts of Brexit on pharmaceutical supply chains.

The theme of the 2019 Forum is excipient integrity. The programme will cover many topics and will include best practices and insights that can help your company adapt to current and future challenges.

This event is an excellent opportunity to network and learn more about the latest developments on pharmaceutical excipients. Pete will be on hand to answer questions and visitors can also get more information on NSF's pharma biotech services, including the 2019 European training offering.

Accommodation will be on site at The Westin Dragonara Resort. You can find out more and register for the event at www.ipec-europe.org.

  • Companies:
  • NSF
See more

You may also like

Finance

Remediating pharmaceutical quality systems

Read more
Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your remediation project a success

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. The colouration of tablets and capsules Paul Smith from Sensient Pharmaceutical Technologies discusses the use of colour in solid oral dosage forms
  3. Production of pharmaceutical compounds through microbial fermentation Most people’s experience of fermentation will be through its most famous and popular use – the brewing of beer
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
  5. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Finance

Remediating pharmaceutical quality systems

Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your remediation project a success
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

Free webinar: Update on EMA and FDA’s approach to tackling drug shortages

The webinar will be hosted on 8 September, 2020 – 1pm BST
Research & Development

How is NSF adapting its services to meet client needs?

As a leader in public health and safety, what has NSF International done to support its clients in the pharma industry?
Manufacturing

Remote and virtual GMP audits from NSF
Regulatory

WHITE PAPER: Live system assessments: Why do them?

Don’t wait for live-systems audits to become mandatory. As more and more companies move to electronic quality management systems, the need for inspectors to conduct audits live in the system has become increasingly common. Prepare now by learning qualification requirements and key advice for installing your own self-inspection program from ex-MHRA inspector Rachel Carmichael.
Digital

Documentation complexity at crisis point?

Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest risk? by Martin Lush
Subscribe now